Nouveau Life Pharmaceuticals, Inc. (NOUV)

0.0002 0.0000 (0.00%) As of 09:30AM EDT. Market open.

Nouveau Life Pharmaceuticals, Inc.

401 East Las Olas Boulevard
Ft. Lauderdale, FL 33301
United States
954-903-2993

Sector(s): Healthcare
Industry: Health Information Services
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Douglas Dickie	Chief Financial Officer and Director	N/A	N/A	1947
Mr. Brian Shibley	Chairman of the Board, CEO & President	N/A	N/A	N/A
Mr. Darcy Penner	Manager of Investor Relations	N/A	N/A	N/A
Mr. Rolly Hein	Acting Vice President and Director	N/A	N/A	1944
Mr. Warren Wheeler	Treasurer, Secretary and Director	N/A	N/A	N/A

Amounts are as of 31 December 2007, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Nouveau Life Pharmaceuticals, Inc., a development stage company, engages in the development of nutraceuticals products. It provides natural alternatives and prescription drugs. The company was formerly known as Hybrid Fuels, Inc. and changed its name to Nouveau Life Pharmaceuticals, Inc. in May 2012. Nouveau Life Pharmaceuticals, Inc. was incorporated in 1998 and is based in Ft. Lauderdale, Florida. Nouveau Life Pharmaceuticals, Inc. operates as a subsidiary of EMG Marketing Solutions, Inc.

Corporate governance

Nouveau Life Pharmaceuticals, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.